Acuta Capital Partners, LLC Pmv Pharmaceuticals, Inc. Call Options Transaction History
Acuta Capital Partners, LLC
- $98.8 Million
- Q3 2024
Call Options
1 transactions
Others Institutions Holding PMVP
# of Institutions
83Shares Held
41.9MCall Options Held
3.1KPut Options Held
1.7K-
Orbimed Advisors LLC San Diego, CA6.48MShares$10.3 Million0.23% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.65MShares$5.8 Million0.08% of portfolio
-
Sio Capital Management, LLC New York, NY3.21MShares$5.11 Million2.53% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.18 Million0.43% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.73 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $72.5M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...